Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Carboxylesterase 1 (CES1) genetic polymorphisms and oseltamivir activation.

Literature DB >> 22847618

Carboxylesterase 1 (CES1) genetic polymorphisms and oseltamivir activation.

Hao-Jie Zhu, John S Markowitz.

Abstract

Entities: Chemical Gene

Mesh：

Substances：

Year: 2012 PMID： 22847618 DOI： 10.1007/s00228-012-1350-2

Source DB: PubMed Journal: Eur J Clin Pharmacol ISSN： 0031-6970 Impact factor: 2.953

× No keyword cloud information.

15 in total

1. A single nucleotide polymorphism in the carboxylesterase gene is associated with the responsiveness to imidapril medication and the promoter activity.

Authors: Eiichi Geshi; Tomomi Kimura; Mika Yoshimura; Hiroshi Suzuki; Shinji Koba; Tetsuo Sakai; Tsukasa Saito; Atsuro Koga; Masaaki Muramatsu; Takashi Katagiri
Journal: Hypertens Res Date: 2005-09 Impact factor: 3.872

2. Genetic variation in carboxylesterase genes and susceptibility to isoniazid-induced hepatotoxicity.

Authors: S Yamada; K Richardson; M Tang; J Halaschek-Wiener; V J Cook; J M Fitzgerald; K Elwood; F Marra; A Brooks-Wilson
Journal: Pharmacogenomics J Date: 2010-03-02 Impact factor: 3.550

3. Anti-influenza prodrug oseltamivir is activated by carboxylesterase human carboxylesterase 1, and the activation is inhibited by antiplatelet agent clopidogrel.

Authors: Deshi Shi; Jian Yang; Dongfang Yang; Edward L LeCluyse; Chris Black; Li You; Fatemeh Akhlaghi; Bingfang Yan
Journal: J Pharmacol Exp Ther Date: 2006-09-11 Impact factor: 4.030

4. Association of a carboxylesterase 1 polymorphism with appetite reduction in children and adolescents with attention-deficit/hyperactivity disorder treated with methylphenidate.

Authors: E M Bruxel; A Salatino-Oliveira; J P Genro; C P Zeni; G V Polanczyk; R Chazan; L A Rohde; M H Hutz
Journal: Pharmacogenomics J Date: 2012-06-12 Impact factor: 3.550

5. Carboxylesterase 1 gene polymorphism and methylphenidate response in ADHD.

Authors: Zsofia Nemoda; Nora Angyal; Zsanett Tarnok; Julia Gadoros; Maria Sasvari-Szekely
Journal: Neuropharmacology Date: 2009-09-04 Impact factor: 5.250

6. Structure and characterization of human carboxylesterase 1A1, 1A2, and 1A3 genes.

Authors: Tatsuki Fukami; Miki Nakajima; Taiga Maruichi; Shiori Takahashi; Masataka Takamiya; Yasuhiro Aoki; Howard L McLeod; Tsuyoshi Yokoi
Journal: Pharmacogenet Genomics Date: 2008-10 Impact factor: 2.089

7. Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: clinical significance and molecular basis.

Authors: Hao-Jie Zhu; Kennerly S Patrick; Hong-Jie Yuan; Jun-Sheng Wang; Jennifer L Donovan; C Lindsay DeVane; Robert Malcolm; Julie A Johnson; Geri L Youngblood; Douglas H Sweet; Taimour Y Langaee; John S Markowitz
Journal: Am J Hum Genet Date: 2008-05-15 Impact factor: 11.025

8. Structural organization and characterization of the regulatory element of the human carboxylesterase (CES1A1 and CES1A2) genes.

Authors: Masakiyo Hosokawa; Tomomi Furihata; Yumiko Yaginuma; Naoko Yamamoto; Natsuko Watanabe; Eiko Tsukada; Yoshiko Ohhata; Kaoru Kobayashi; Testuo Satoh; Kan Chiba
Journal: Drug Metab Pharmacokinet Date: 2008 Impact factor: 3.614

3. Similarity-Based Analysis of Allele Frequency Distribution among Multiple Populations Identifies Adaptive Genomic Structural Variants.

Authors: Marie Saitou; Naoki Masuda; Omer Gokcumen
Journal: Mol Biol Evol Date: 2022-03-02 Impact factor: 8.800

3 in total